Antinori, A.
Lazzarin, A.
Uglietti, A.
Palma, M.
Mancusi, D.
Termini, R.
Article History
Received: 25 September 2017
Accepted: 12 March 2018
First Online: 27 March 2018
Competing Interests
: Andrea Antinori (A.A.) has received honoraria for consultancies with Gilead Sciences, ViiV Healthcare, Merck Sharp & Dohme, Janssen-Cilag, Abbvie, and Bristol-Myers Squibb and has also received research grants from Gilead Sciences, Bristol-Myers Squibb, Janssen-Cilag, and ViiV Healthcare; Adriano Lazzarin (A.L.) has received fees for advisory board participation and conference talks from BMS, ViiV, Gilead, MSD, Mylan, Abbvie, Janssen Cilag, and Teva; Alessia Uglietti (A.U.), Maria Palma (M.P.), Daniela Mancusi (D.M.) and Roberta Termini (R.T.) are employees of Janssen-Cilag SpA, Italy.